Menu
ETF
Annual · values202520242023202220212020201920182017201620152014
Operating Cash Flow-13.05 M USD-8.83 M USD-8.53 M USD-11.55 M USD-9.35 M USD-7.25 M USD-6.45 M USD-5.31 M USD-4.86 M USD-786000 USD-30.68 M USD-27.35 M USD
Depreciation & Amortization47000 USD91000 USD106000 USD102000 USD76000 USD68000 USD84000 USD54000 USD21000 USD10000 USD1.13 M USD1.31 M USD
Stock-Based Compensation1.06 M USD1.35 M USD1.39 M USD1.75 M USD1.39 M USD1.94 M USD1.10 M USD1.40 M USD479000 USD676000 USD4.24 M USD2.03 M USD
Capital Expenditures60000 USD25000 USD33000 USD84000 USD69000 USD91000 USD216000 USD223000 USD58000 USD25000 USD1.05 M USD903943 USD
Cash Flow from Investing-72.38 M USD1.54 M USD1.97 M USD-3.84 M USD3.20 M USD-2.77 M USD-2.45 M USD-223000 USD-85000 USD-25000 USD-885280 USD-425622 USD
Cash Flow from Financing86.24 M USD7.94 M USD6.56 M USD4.32 M USD-3.38 M USD36.77 M USD-18000 USD13.02 M USD3.08 M USD18.71 M USD22.20 M USD
Dividends Paid
Stock Buybacks
Free Cash Flow-13.11 M USD-8.85 M USD-8.57 M USD-11.63 M USD-9.42 M USD-7.34 M USD-6.67 M USD-5.53 M USD-4.91 M USD-811000 USD-31.73 M USD-28.26 M USD

Microbot Medical Inc. is a cutting-edge medical device company focused on enhancing healthcare through innovative technologies. The company's primary function is to develop micro-robotic medical solutions, with an emphasis on improving minimally invasive surgeries and medical procedures. This focus addresses the growing demand for precision, efficacy, and less invasive treatment options within the healthcare sector. Notably, Microbot Medical Inc. is pioneering advancements in the field of robotic technology to facilitate endoluminal procedures, which involve navigation through natural body lumens such as blood vessels or the gastrointestinal tract. With its headquarters in Massachusetts, USA, the company plays a significant role in the medical device market, contributing to the ongoing evolution of surgical practices and patient care. As healthcare providers increasingly prioritize technological advancements to reduce recovery times and enhance procedural accuracy, Microbot Medical Inc.'s innovations become crucial to achieving these goals. The company's commitment to micro-robotics positions it as a transformative entity within the healthcare technology landscape.